Skip to content

Opening book details…

Can I read Ethical Aspects of Placebo in Migraine Research on EtoBox?

Ethical Aspects of Placebo in Migraine Research by M Linde; A May; V Limmroth; C Dahlöf; on behalf of the Headache Masters Programme is a Medicine article available to read on EtoBox.

What is Ethical Aspects of Placebo in Migraine Research about?

Randomized placebo-controlled clinical trials have been the ‘golden standard’ during the last decades in the development of new drug therapies. This scientifically valid approach has recently been questioned in the fifth revised version of the Declaration of Helsinki, which states that the use of placebo-controlled clinical trials is only acceptable when no proven treatment exists for the studied disease. The World Medical Association further claims that no national ethical, legal or regulatory requirements should be allowed to reduce or eliminate any of the statements in the declaration. In spite of this, the document is not generally accepted as the world ethical standard, as demonstrated by its lack of adoption by many professional associations. In the evaluation process for a drug to be approved in many countries today, clinical investigators at the hospitals and researchers at the pharmaceutical companies are obliged to use study protocols that would be rejected if the new declaration were to be fully adopted. Adherence to the clinical trial guidelines of the International Headache Society could also mean violation of the new Helsinki declaration of ethics. Some ethics committ

Who reads Ethical Aspects of Placebo in Migraine Research?

It is typically read by researchers, students, and practitioners in Medicine.

Author
M Linde; A May; V Limmroth; C Dahlöf; on behalf of the Headache Masters Programme
Publisher
John Wiley and Sons; SAGE Publications; Wiley (ISSN 0333-1024)
Published
2003
Language
EN
Field
Medicine (Health Sciences)

More by M Linde; A May; V Limmroth; C Dahlöf; on behalf of the Headache Masters Programme

Browse all works by M Linde; A May; V Limmroth; C Dahlöf; on behalf of the Headache Masters Programme